From the publishers of JADPRO

MPN Resource Center

Advertisement

Appropriate management of polycythaemia vera with cytoreductive drug therapy: European LeukemiaNet 2021 recommendations

Last Updated: Thursday, August 4, 2022

These recent European LeukemiaNet recommendations focus on the use of newly approved therapies for the treatment of polycythemia vera, including ropeginterferon alfa-2b and ruxolitinib.

The Lancet Hematology
Advertisement
News & Literature Highlights
Advertisement
Advertisement